Broad Institute
OCTOBER 28, 2024
Scientists then annotate the cells with this information, a process that can take days or even weeks, depending on the number of cells being labeled, and requires labor-intensive literature and database searches. We wanted to build a tool like that for cell biology. It’s basically a search engine.
Chemical Biology and Drug Design
JULY 26, 2023
Exosome engineering can be conducted through surface and content modification of biological exosomes. In preisolation method, parental cells are stimulated to express some special genes like lncRNAs, miRNAs, and receptors to have the capacity to bind to the target cells and deliver their content.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
JULY 13, 2023
The aim is to establish condensate biology as a fundamental branch of cell biology – “cell biology 2.0” The underlying biology and processes upon which the company was founded have broad applicability across various human disease areas. Klein notes the importance of Dewpoint’s disease-agnostic approach.
Drug Target Review
OCTOBER 16, 2023
Two-dimensional cell models were the cornerstone of cellular assays in early drug discovery for years, yet the system lacks the genetic and epigenetic background of the patient and the cell-to-cell spatial architecture and cellular signalling between cells of different types within the tissue architecture.
Broad Institute
NOVEMBER 2, 2023
At the Broad Institute of MIT and Harvard, a group of researchers, software engineers, administrators, and communicators (yes, us) has been exploring the use of these chatbots and similar tools, surveying the community and developing recommendations. So you have to do your own fact-checking.
Drug Target Review
JUNE 5, 2023
ZW191 is an antibody-drug conjugate (ADC) that is engineered to target folate receptor-⍺ (FR⍺), a protein that has limited expression in normal tissues but is often elevated on a variety of tumours including epithelial ovarian, endometrial, triple negative breast and lung adenocarcinoma.
Drug Target Review
NOVEMBER 17, 2023
She obtained her PhD from the University of Wollongong in 2015 and gained extensive research experience as a postdoctoral fellow at Swinburne University of Technology, CSIRO, and Monash University, in the fields of immunology and tissue engineering.
Expert insights. Personalized for you.
119 
Let's personalize your content